Adage Capital Management, L.P. 13D and 13G filings for EyePoint Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-13 09:07 am Sale | 2025-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Adage Capital Management, L.P. | 5,559,782 8.070% | -1,240,218 (-18.24%) | Filing |
| 2025-08-12 09:07 am Purchase | 2025-06-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Adage Capital Management, L.P. | 6,800,000 9.880% | 1,050,000 (+18.26%) | Filing |
| 2025-02-12 09:33 am Purchase | 2024-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Adage Capital Management, L.P. | 5,750,000 8.420% | 1,958,580 (+51.66%) | Filing |
| 2024-11-12 09:33 am Sale | 2024-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Adage Capital Management, L.P. | 3,791,420 7.080% | -1,364,879 (-26.47%) | Filing |
| 2024-05-01 5:08 pm Unchanged | 2024-04-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Adage Capital Management, L.P. | 5,156,299 9.900% | 0 (Unchanged) | Filing |
| 2024-04-30 8:53 pm Purchase | 2024-04-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Adage Capital Management, L.P. | 5,156,299 10.350% | 5,156,299 (New Position) | Filing |